New research reveals that seeing a weight management specialist alongside your diabetes doctor can dramatically boost your success with GLP-1 medications like Ozempic.
A groundbreaking study from the University of Iowa shows that patients using GLP-1 medications like Ozempic and Wegovy achieve significantly better weight loss results when they combine diabetes care with specialized weight management visits. The research found that people who attended at least four weight management appointments lost considerably more weight than those receiving standard diabetes care alone.
What Makes Weight Management Specialists Different?
While your regular diabetes doctor focuses on blood sugar control and complications like diabetic eye disease, weight management specialists take a completely different approach. Dr. Kathleen Robinson, the University of Iowa endocrinologist who led the study, explains the challenge: "The American Diabetes Association recommends addressing weight for patients with diabetes, but there are so many things to manage in those visits that it becomes very difficult to have a detailed conversation about lifestyle changes, and weight in and of itself."
Weight management specialists provide comprehensive support that goes far beyond prescribing semaglutide or other glucagon-like peptide-1 (GLP-1) medications. Their specialized approach includes several key components:
- Detailed Dietary Tracking: Specialists work with patients to develop sustainable eating patterns and monitor food intake over time, rather than offering generic advice
- Personalized Physical Activity Plans: They create exercise strategies tailored to individual limitations and gradually build activity levels as weight loss progresses
- Mental Health Integration: Weight management clinics often coordinate with mental health providers to address emotional eating, food relationships, and psychological barriers to weight loss
- Medication Optimization: These specialists stay current with the latest research on GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) medications, ensuring patients receive the most appropriate treatment for their specific conditions
Why Four Visits Make the Difference?
The University of Iowa study tracked patients over five years and made a surprising discovery about visit frequency. While both groups experienced significant improvements in hemoglobin A1c (blood sugar control), weight, and low-density lipoprotein (LDL) cholesterol levels, the magic number appeared to be four weight management visits. Patients who attended only one consultation actually experienced less weight loss than those who received standard diabetes care alone.
This finding suggests that successful weight management requires sustained engagement rather than one-time consultations. Dr. Marcelo Correia, another University of Iowa endocrinologist involved in the research, believes this approach is particularly valuable for people with clinical obesity—defined as excess weight that impairs daily activities and organ function, beyond just having a high body mass index (BMI).
Who Benefits Most from Dual Care?
The research indicates that weight management specialists are especially equipped to help patients with multiple health conditions. "One example would be for a patient with obesity, diabetes, and coronary artery disease," Correia explained. "This is a common patient, and this patient may benefit from a weight management clinic because they will likely benefit from weight loss. And secondly, we can use data from clinical trials to recommend specific medications for weight management and diabetes in patients with coronary artery disease. For example, semaglutide has an indicator for this specific case."
Weight management specialists also stay current with the rapidly evolving landscape of incretin therapy, including medication pricing and availability. This expertise becomes crucial as insurance coverage changes and new formulations become available. The specialists can help patients navigate these challenges while maintaining consistent treatment.
The study authors emphasize that incretin therapies like GLP-1 and GIP medications can serve as a gateway to other health improvements. For instance, a person who loses weight with these medications might become eligible for joint replacement surgery that was previously too risky, ultimately enabling them to become more physically active and maintain their weight loss long-term.
As access to GLP-1 medications continues to expand, Robinson sees this as just the beginning of understanding how to optimize these powerful tools. "I think we're in a really exciting era for weight management and weight management providers," she said. "It's not just about weight; it's really about the metabolic health outcomes and helping people achieve the health that they're looking for."
Next in Weight Management
→ Popular Weight Loss Drugs Work Fast—But the Weight Comes Back Even FasterPrevious in Weight Management
← The Hidden Risks of Diet Pills: Why the Quick Fix Often BackfiresSource
This article was created from the following source:
More from Weight Management
The Weight Regain Problem Nobody Warns You About When Stopping GLP-1 Drugs
People regain weight faster after stopping GLP-1 medications than other weight loss methods—averaging 2 pounds monthly....
Feb 20, 2026
Why Intermittent Fasting Might Work for You—Even If It's Not a Weight Loss Shortcut
Intermittent fasting doesn't beat regular calorie restriction for weight loss, but it may help some people stick to their goals....
Feb 19, 2026
The Rapid Weight Loss Trap: Why Slow and Steady Actually Wins
Research shows most people who lose weight quickly regain it—and sometimes more. Here's what science says about sustainable weight loss versus crash d...
Feb 18, 2026